How do GLP-1 drugs work for weight loss?
Dr. Mehmet Furkan Burak said people who have lost weight and then gained it again can feel guilt or shame and blame themselves for it.
GLP-1 Drugs For Weight Loss Aren’t Cost-Saving Yet
Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug spending. But thus far, the data don’t show this.
GLP-1 drug use cuts grocery spending by 6%, study finds
Purchases of calorie-dense, processed items such as chips, baked goods and cookies were most affected, according to findings by Cornell University and Numerator.
Illinois AG Raoul: exercise caution with GLP-1 drugs for weight loss
Attorney General Kwame Raoul is warning Illinois residents seeking GLP-1 medications – Ozempic, Wegovy, Mounjaro, Zepbound and others – that many sellers advertising these name brand medications are i
Some GLP-1s Achieve More Weight Loss Than Others: Study
We found that, of the 12 GLP-1 (drugs) identified by our search, the greatest mean body weight reduction was reported in randomized controlled trials of retatrutide, tirzepatid
GLP-1 RAs Efficacious for Weight Loss in Overweight, Obesity Without Diabetes
For adults with overweight or obesity without diabetes, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are efficacious for weight loss, according to a review published online Jan. 7 in the Annals of Internal Medicine.
Health Matters: GLP-1 drugs work for weight loss, study finds
McGill University researchers say their study has found GLP-1 drugs are safe and effective for treating obesity and overweight adults without diabetes. The authors say the findings support using the medication to treat those who are overweight and obese among otherwise healthy patients.
FoodNavigator3h
Which GLP-1 drugs are on the market?
A range of GLP-1 weight loss drugs are currently on the market. What are they, what do they do, and where are they available?
GlobalData on MSN1d
GLP-1 drugs reduce US grocery spending by 6%, study claims
GLP-1 drugs, such as Wegovy and Ozempic, are gaining popularity in the US and Europe for their appetite-suppressing ...
FierceBiotech1d
Metsera links GLP-1 drug to 11% weight loss after 12 weeks, teeing up trial of monthly dosing
Metsera has linked its GLP-1 drug candidate to weight loss of up to 11.3% after 12 weeks, encouraging the biotech to use some ...
Get the skinny on GLP-1 agonist medications
Achieving and maintaining a healthy weight is beneficial for a number of reasons. A healthy weight lowers a person's chance ...
FiercePharma9d
2025 forecast: After Novo, Lilly expansion sprees, 'positive signals' emerge around future supply of GLP-1 drugs
Following rapid (and pricey) expansion efforts from Novo and Lilly, plus recent shortage updates at the FDA, “positive ...
Hosted on MSN6d
GLP-1 withdrawal can have lasting health effects
The surging popularity of GLP-1 drugs is beginning to obscure the health consequences if people stop taking them, physicians ...
Becker's Hospital Review12d
The GLP-1 dilemma persists into 2025
MassHealth is transitioning coverage for anti-obesity drugs, designating Zepbound as the preferred option starting in January 2025, with Wegovy and Saxenda being discontinued for most adult members.
GLP-1 questions emerge for 2025
The weight-loss market began feeling some growing pains as the year ended, creating more wariness for the upcoming year. For ...